SightfileU.S. market data from official filings
Companies › MSLE
SATELLOS BIOSCIENCE INC (MSLE)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001421642 · EDGAR filings · Updated 2026-07-08
SATELLOS BIOSCIENCE INC (MSLE) has reported institutional ownership of 49.1%, with 31 institutional managers holding positions valued at $42.8M per the latest 13F reporting period.
Institutional ownership
49.1%
Institutional managers
31
Reported 13F value
$42.8M
Latest updates
- 2026-07-08 — Foreign issuer report (6-K) filed
- 2026-06-29 — Foreign issuer report (6-K) filed
- 2026-06-25 — Foreign issuer report (6-K) filed
- 2026-06-18 — Foreign issuer report (6-K) filed
- 2026-06-17 — Foreign issuer report (6-K) filed
- 2026-05-27 — Foreign issuer report (6-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, SATELLOS BIOSCIENCE INC has 31 institutional holders and institutional ownership of 49.1%.
Related companies
CARTESIAN THERAPEUTICS INC (RNAC) · ATYR PHARMA INC (ATYR) · Adicet Bio Inc (ACET) · Rallybio Corp (RLYB) · GREENWICH LIFESCIENCES INC (GLSI) · PULMONX CORP (LUNG)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-08.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-08.